Development and validation of the disease-specific Short Bowel Syndrome-Quality of Life (SBS-QoL™) scale

P Berghöfer; K C Fragkos; J P Baxter; A Forbes; F Joly; H Heinze; S Loth; M Pertkiewicz; B Messing; P B Jeppesen

doi:10.1016/j.clnu.2012.12.001

Development and validation of the disease-specific Short Bowel Syndrome-Quality of Life (SBS-QoL™) scale

P Berghöfer, K C Fragkos, J P Baxter, A Forbes, F Joly, H Heinze, S Loth, M Pertkiewicz, B Messing, P B Jeppesen

Research output: Contribution to journal › Article › peer-review

48 Citations (Scopus)

Abstract

Subjects with short bowel syndrome (SBS) have impaired quality of life (QoL). No disease-specific instrument has been available to measure treatment-induced changes in QoL over time. Therefore, the aim was to develop and validate an SBS-specific QoL scale.

Original language	English
Pages (from-to)	789-96
Number of pages	8
Journal	Clinical Nutrition
Volume	32
Issue number	5
DOIs	https://doi.org/10.1016/j.clnu.2012.12.001
Publication status	Published - Oct 2013

Keywords

Activities of Daily Living
Adult
Aged
Cost of Illness
Diarrhea
Double-Blind Method
Drug Resistance
Female
Gastrointestinal Agents
Gastrointestinal Tract
Humans
Male
Middle Aged
Peptides
Psychometrics
Quality of Life
Questionnaires
Receptors, Glucagon
Recombinant Proteins
Reproducibility of Results
Severity of Illness Index
Short Bowel Syndrome

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.clnu.2012.12.001

Cite this

@article{414774c345a246eabd9822b02ff0ec9b,

title = "Development and validation of the disease-specific Short Bowel Syndrome-Quality of Life (SBS-QoL{\texttrademark}) scale",

abstract = "Subjects with short bowel syndrome (SBS) have impaired quality of life (QoL). No disease-specific instrument has been available to measure treatment-induced changes in QoL over time. Therefore, the aim was to develop and validate an SBS-specific QoL scale.",

keywords = "Activities of Daily Living, Adult, Aged, Cost of Illness, Diarrhea, Double-Blind Method, Drug Resistance, Female, Gastrointestinal Agents, Gastrointestinal Tract, Humans, Male, Middle Aged, Peptides, Psychometrics, Quality of Life, Questionnaires, Receptors, Glucagon, Recombinant Proteins, Reproducibility of Results, Severity of Illness Index, Short Bowel Syndrome",

author = "P Bergh{\"o}fer and Fragkos, {K C} and Baxter, {J P} and A Forbes and F Joly and H Heinze and S Loth and M Pertkiewicz and B Messing and Jeppesen, {P B}",

year = "2013",

month = oct,

doi = "10.1016/j.clnu.2012.12.001",

language = "English",

volume = "32",

pages = "789--96",

journal = "Clinical Nutrition",

issn = "0261-5614",

publisher = "Churchill Livingstone",

number = "5",

}

TY - JOUR

T1 - Development and validation of the disease-specific Short Bowel Syndrome-Quality of Life (SBS-QoL™) scale

AU - Berghöfer, P

AU - Fragkos, K C

AU - Baxter, J P

AU - Forbes, A

AU - Joly, F

AU - Heinze, H

AU - Loth, S

AU - Pertkiewicz, M

AU - Messing, B

AU - Jeppesen, P B

PY - 2013/10

Y1 - 2013/10

N2 - Subjects with short bowel syndrome (SBS) have impaired quality of life (QoL). No disease-specific instrument has been available to measure treatment-induced changes in QoL over time. Therefore, the aim was to develop and validate an SBS-specific QoL scale.

AB - Subjects with short bowel syndrome (SBS) have impaired quality of life (QoL). No disease-specific instrument has been available to measure treatment-induced changes in QoL over time. Therefore, the aim was to develop and validate an SBS-specific QoL scale.

KW - Activities of Daily Living

KW - Adult

KW - Aged

KW - Cost of Illness

KW - Diarrhea

KW - Double-Blind Method

KW - Drug Resistance

KW - Female

KW - Gastrointestinal Agents

KW - Gastrointestinal Tract

KW - Humans

KW - Male

KW - Middle Aged

KW - Peptides

KW - Psychometrics

KW - Quality of Life

KW - Questionnaires

KW - Receptors, Glucagon

KW - Recombinant Proteins

KW - Reproducibility of Results

KW - Severity of Illness Index

KW - Short Bowel Syndrome

U2 - 10.1016/j.clnu.2012.12.001

DO - 10.1016/j.clnu.2012.12.001

M3 - Article

C2 - 23274148

VL - 32

SP - 789

EP - 796

JO - Clinical Nutrition

JF - Clinical Nutrition

SN - 0261-5614

IS - 5

ER -